Literature DB >> 16920242

The myth of agency and patient choice in health care? The case of drug treatments to prevent coronary disease.

Stirling Bryan1, Paramjit Gill, Sheila Greenfield, Kerry Gutridge, Tom Marshall.   

Abstract

Patient choice is at the heart of health-care reform programmes in the UK and in many other countries. The success of patient choice initiatives is dependent on a well-functioning agency relationship in health care. We interviewed 197 patients from 13 general practices in the West Midlands, UK, both before and after coronary screening. Our study suggests that, for patients presenting for coronary risk screening in primary care, the agency relationship is not working well--patients' expressed preferences relating to decisions to commence drug treatments were largely over-ridden in the clinical consultation. Therefore, if choice is to be a real driver of change in health care it needs to encompass patient empowerment and be based on a more collaborative approach to decision making between patients and professionals.

Entities:  

Mesh:

Year:  2006        PMID: 16920242     DOI: 10.1016/j.socscimed.2006.07.008

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  Agency and choice in genetic counseling: Acknowledging patients' concerns.

Authors:  Kieran O'Doherty
Journal:  J Genet Couns       Date:  2009-10       Impact factor: 2.537

2.  Conducting discrete choice experiments to inform healthcare decision making: a user's guide.

Authors:  Emily Lancsar; Jordan Louviere
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

3.  Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study.

Authors:  Nicola K Gale; Sheila Greenfield; Paramjit Gill; Kerry Gutridge; Tom Marshall
Journal:  BMC Fam Pract       Date:  2011-06-26       Impact factor: 2.497

4.  Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack.

Authors:  Tian-Tian Ma; Ian C K Wong; Cate Whittlesea; Kenneth K C Man; Wallis Lau; Zixuan Wang; Ruth Brauer; Thomas M MacDonald; Isla S Mackenzie; Li Wei
Journal:  BMC Med       Date:  2021-02-03       Impact factor: 8.775

Review 5.  Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature.

Authors:  Stacey L Sheridan; Eric Crespo
Journal:  BMC Health Serv Res       Date:  2008-03-20       Impact factor: 2.655

6.  Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.

Authors:  Jianhua Wu; Shihua Zhu; Guiqing Lily Yao; Mohammed A Mohammed; Tom Marshall
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.